Natco Pharma Limited has informed the Exchange regarding a press release dated November 20, 2026, titled “NATCO receives Establishment Inspection Report (EIR) from the U.SFood and Drug Administration (FDA) Inspection at our Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit”|SUBJECT: Press Release
Source link